Skip to content
★ Sign in to follow
JP

John P. Saharek

Executive
Chairman & CEO
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 07 Apr 2025 for HARROW, INC., €2.3M.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

John P. Saharek: trading record in brief

John P. Saharek is a declared insider of Harrow, Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 1 February 2015 to 7 April 2025, the count stands at 15 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 7 April 2025 with a share grant (€2.3M) in Harrow, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to John P. Saharek

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◆
    CEO & President, ImprimisRxExecutivesHarrow, Inc.
    3M USD25SEC
    109,475 shares@ US$23.0932.2% of flowCommon StockSEC:0001641172-25-003111:1
  • ◇
    CEO & President, ImprimisRxExecutivesHarrow, Inc.
    0SEC
    277,200 shares0Common StockSEC:0001641172-25-003111:0
  • ◆
    CEO of ImprimisRxExecutivesHarrow, Inc.
    2M USD24SEC
    45,140 shares@ US$41.3723.6% of flowCommon stockSEC:0001493152-24-036244:1
  • ◇
    CEO of ImprimisRxExecutivesHarrow, Inc.
    663,300 USD28SEC
    90,000 shares@ US$7.3764.1% of flowCommon stockSEC:0001493152-24-036244:0
  • ◇
    CEO of ImprimisRxExecutivesHarrow, Inc.
    43,750 USD22SEC
    5,000 shares@ US$8.754.3% of flowCommon stockSEC:0001493152-24-008930:0
  • ◇
    CEO of ImprimisRxExecutivesHarrow, Inc.
    134,613 USD22SEC
    12,616 shares@ US$10.671.7% of flowCommon stockSEC:0001493152-24-007456:1
  • ◇
    CEO of ImprimisRxExecutivesHarrow, Inc.
    320,100 USD25SEC
    30,000 shares@ US$10.6731.6% of flowCommon stockSEC:0001493152-24-007456:0
  • ◆
    Chief Commercial OfficerExecutivesHarrow, Inc.
    125,452 USD11SEC
    9,778 shares@ US$12.833.9% of flowCommon StockSEC:0001493152-23-041355:1
  • ◇
    Chief Commercial OfficerExecutivesHarrow, Inc.
    0SEC
    20,000 sharesCommon StockSEC:0001493152-23-041355:0
  • ◆
    Chief Commercial OfficerExecutivesHarrow, Inc.
    2M USD13SEC
    109,080 shares@ US$18.2324.6% of flowCommon StockSEC:0001493152-23-025148:1
  • ◇
    Chief Commercial OfficerExecutivesHarrow, Inc.
    0SEC
    277,200 sharesCommon StockSEC:0001493152-23-025148:0
  • ◆
    President, ImprimisRxExecutivesHarrow, Inc.
    204,014 USD22SEC
    25,923 shares@ US$7.872.5% of flowCommon StockSEC:0001493152-22-005270:1
  • ◇
    President, ImprimisRxExecutivesHarrow, Inc.
    0SEC
    50,000 sharesCommon StockSEC:0001493152-22-005270:0
  • ◇
    Chief Commercial OfficerExecutivesHarrow, Inc.
    54,900 USD11SEC
    30,000 shares@ US$1.834.5% of flowCommon StockSEC:0001493152-18-001437:0
  • ◆
    Chief Commercial OfficerExecutivesHarrow, Inc.
    0SEC
    30,000 shares0Common StockSEC:0001493152-15-000353:0

15 of 15 declarations